[1]
“Genetic Polymorphism in CYP3A4 and CYP3A5 Genes and their Association with the Clinical Response to Calcineurin Inhibitors; A Narrative Review”, Precis. Med. Com., vol. 4, no. 01, pp. 21–40, Jun. 2024, doi: 10.55627/pmc.004.001.0554.